Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P010032/S261

Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) Charger

ABBOTT MEDICAL · Decision date Sep 11, 2026

MEDTECHLEDGER EXPLANATIONP010032/S261

What did the FDA decide?

The FDA record lists supplement P010032/S261 for Abbott Medical, a 30-Day Notice under the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier, decided OK30 on 2026-09-11. The reported purpose is approval to use an alternate third-tier supplier for the FR-4 material in printed circuit boards for Chargers of the Eterna SCS IPG and Liberta RC DBS IPG. The device category is Stimulator, spinal-cord, totally implanted for pain relief, product code LGW, specialty Neurology.

The P010032 identifier ties this to the original PMA for that spinal-cord stimulator system; the notice covers a supplier change, not a new approval of the system or a new indication. The record does not state which supplier, qualification testing, FR-4 specification, or any safety or effectiveness data, and the OK30 decision reflects the agency's action on the notice rather than independent clinical evidence.

FDA approval order statement

approval to utilize an alternate third-tier supplier for the FR-4 material, which is used in the manufacture of the printed circuit boards for the Chargers of the Eterna SCS IPG and Liberta RC DBS IPG
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Neurology
Decision date
Sep 11, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P010032/S261
Regulatory pathway
PMA supplement
Product code
LGW
Decision code
OK30
Decision date
Sep 11, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stimulator, spinal-cord, totally implanted for pain relief.

Product code
LGW
FDA device class
3

For the original device and its historical approval scope, see PMA P010032. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P010032 · Original PMA

    GENESIS AND EON FAMILY NEUROSTIMULATION (IPG) SYSTEMS

  2. P010032/S261 received

    Application receipt date recorded by FDA.

  3. P010032/S261 · FDA decision

    30-Day Notice

  4. P010032/S251 · Related supplement

    Quattrode; Octrode; Penta; Lamitrode; Tripole; TriCentrus Lead Extensions

  5. P010032/S260 · Related supplement

    Proclaim family of SCS IPG

  6. P010032/S265 · Related supplement

    Eterna Spinal Cord Stimulation (SCS) Implantable Pulse Generator

  7. P010032/S262 · Related supplement

    Spinal Cord Stimulation (SCS) External Pulse Generator (EPG)

  8. P010032/S264 · Related supplement

    Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) Charger

  9. P010032/S266 · Related supplement

    Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG)

Timeline entries are records held by MedtechLedger for P010032. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P010032

Explore the linked device profile

Other records with product code LGW

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
6901 Preston Rd., Plano, TX, 75024

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records